EUVIMEDEUVIMED entdecken
Open Access

Efficacy of thermal ablation for treatment of biopsy‐confirmed high‐grade cervical precancer among women living with HIV in Kenya

Chemtai Mungo iD, Cirilus Ogollah Osongo, Jeniffer Ambaka, Jackton Omoto, Craig R Cohen

International Journal of Cancer · 15.12.2023 · 153 (12) · 1971-1977

DOI: 10.1002/ijc.34737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 15.09.2023. Verfasst von Chemtai Mungo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia, HIV Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NICHD NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization recommends thermal ablation (TA) as an alternative to cryotherapy within “screen‐and‐treat” cervical cancer programs in low‐ and middle‐income countries (LMICs), including among women living with HIV (WLWH). Data on TA efficacy among WLWH are limited, however. We conducted a clinical trial to evaluate efficacy of TA for treatment of biopsy‐confirmed cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3) among WLWH in Kenya. Nonpregnant HPV‐positive WLWH age 25 to 65 years underwent colposcopy‐directed biopsy, and same‐day treatment with TA, if eligible. Women with biopsy‐confirmed CIN2/3 at baseline had colposcopy‐directed biopsies at 12 months to determine cure. A total of 376 participants underwent TA during the study period. At baseline, 238 (63.3%) had normal histology, 39 (10.4%) had CIN1, 15 (4.0%) had CIN2, 55 (14.6%) had CIN3, 7 (1.9%) had microinvasive cancer and 22 (5.6%) had indeterminate results. Twelve‐month follow‐up pathology results are available for 59 of 70 (84.3%) participants with CIN2/3 at baseline. Of these, 39 (66.1%, 95% CI 0.54‐0.99) had successful treatment, defined as biopsy‐confirmed CIN1 or normal findings, while 20 (33.9%, 95% CI 0.22‐0.46) had treatment failure, defined as persistent biopsy‐confirmed CIN2 or worse. Treatment failure was 23.1% (95% CI 0.17‐0.46) and 39.9% (95% CI 0.23‐0.51) among women with CIN2 and CIN3 at baseline, respectively. HIV‐positive women with CIN2/3 have high rates of treatment failure at 1‐year following thermal ablation. This highlights a significant limitation in the current WHO cervical cancer secondary‐prevention strategy and calls for strategies to optimize cervical precancer treatment in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsUterine Cervical DysplasiaHIV InfectionsFemaleHumansAdultMiddle AgedAgedPregnancyKenyaBiopsyColposcopyPapillomaviridae

Stichwörter der Autor:innen

CIN2/3low- and middle-income countriesthermal ablation efficacywomen living with HIV

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Kenya Medical Research Institute, Kisumu, Kenya.
  • Department of Obstetrics and Gynecology, Maseno University School of Medicine, Kisumu, Kenya.
  • Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Chemtai Mungo

Förderung

  • FIC NIH HHS
  • NICHD NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Mungo, C., Osongo, C. O., Ambaka, J., Omoto, J., & Cohen, C. R. (2023). Efficacy of thermal ablation for treatment of biopsy‐confirmed high‐grade cervical precancer among women living with HIV in Kenya. International Journal of Cancer, 153(12), 1971-1977. https://doi.org/10.1002/ijc.34737

Vancouver

Mungo C, Osongo CO, Ambaka J, Omoto J, Cohen CR. Efficacy of thermal ablation for treatment of biopsy‐confirmed high‐grade cervical precancer among women living with HIV in Kenya. International Journal of Cancer. 2023;153(12):1971-1977. doi:10.1002/ijc.34737

BibTeX
@article{Mungo2023,
  author = {Mungo, Chemtai and Osongo, Cirilus Ogollah and Ambaka, Jeniffer and Omoto, Jackton and Cohen, Craig R},
  title = {Efficacy of thermal ablation for treatment of biopsy‐confirmed high‐grade cervical precancer among women living with HIV in Kenya},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {153},
  number = {12},
  pages = {1971--1977},
  doi = {10.1002/ijc.34737}
}
Kostenlos starten →